Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: ACT-541468
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.